| 产品名称： | Escherichia coli (Migula) Castellani and Chalmers |
|---|---|
| 商品货号： | TS152744 |
| Classification： | Enterobacteriaceae, Escherichia |
| Strain Designations： | 27C7 |
| Application： | Transformation host |
| Isolation： | Derived from existing strain, W3110, ATCC 27325 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Genotype： | tonA ptr3 deltaphoA deltaE15 delta(argF-lac)169 degP41 deltaompT; |
| Type Strain： | no |
| Antibiotic Resistance： | Kanamycin-resistant |
| Comments： | kanamycin-resistant Protease-deficient |
| Medium： | ATCC® Medium 1065: LB Agar/Broth, Miller |
| Growth Conditions： | Temperature: 30°C Atmosphere: Aerobic |
| Name of Depositor： | Genentech, Inc. |
| U.S. Patent Number： | |
| References： | McFarland NC, et al. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation. US Patent 5,288,931 dated Feb 22 1994 |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Escherichia coli (Migula) Castellani and Chalmers |
|---|---|
| 商品货号： | TS152744 |
| Classification： | Enterobacteriaceae, Escherichia |
| Strain Designations： | 27C7 |
| Application： | Transformation host |
| Isolation： | Derived from existing strain, W3110, ATCC 27325 |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Genotype： | tonA ptr3 deltaphoA deltaE15 delta(argF-lac)169 degP41 deltaompT; |
| Type Strain： | no |
| Antibiotic Resistance： | Kanamycin-resistant |
| Comments： | kanamycin-resistant Protease-deficient |
| Medium： | ATCC® Medium 1065: LB Agar/Broth, Miller |
| Growth Conditions： | Temperature: 30°C Atmosphere: Aerobic |
| Name of Depositor： | Genentech, Inc. |
| U.S. Patent Number： | |
| References： | McFarland NC, et al. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation. US Patent 5,288,931 dated Feb 22 1994 |
